Characterising spatial heterogeneity of multiple myeloma in high resolution by whole body magnetic resonance imaging: Towards macro-phenotype driven patient management
Arash Latifoltojar, Kevin Boyd, Angela M. Riddell, Martin Kaiser, Christina Messiou
Abstract
Diagnosis of patients suspected of multiple myeloma requires a combination of serological and biochemical tests, bone marrow aspirate (BMA) and/or bone marrow trephine (BMT) biopsies as well as complementary information provided by whole-body cross-sectional imaging studies. However, given the heterogeneous nature of multiple myeloma, discrepancies can arise between disease burden on trephine and extent of disease within the marrow on whole-body magnetic resonance imaging (WB-MRI). Here, for the first time, we report on a series of symptomatic multiple myeloma patients for whom there was substantial discordance between disease burden on trephine and WB-MRI.
Topics & Concepts
Multiple myelomaTrephineMagnetic resonance imagingMedicineBone marrowRadiologyPathologyInternal medicineMultiple Myeloma Research and TreatmentsMalaria Research and ControlCancer Treatment and Pharmacology